Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
Plos One
|
March 28, 2017
Common and rare exonic MUC5B variants associated with type 2 diabetes in Han Chinese
Guanjie Chen, Zhenjian Zhang, Sally N Adebamowo, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 22, 2023
Diagnostic efficiency of [68 Ga]Ga-DOTA-FAPI-04 in differentiating periprosthetic hip joint infection and aseptic failure
Yiqun Wang, Ruimin Wang, Xiaojun Zhang, et al.
Haematologica
|
April 24, 2025
The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significance-like behavior predict an exceptionally favorable prognosis in multiple myeloma
Wenqiang Yan, Chen Qiu, Jieqiong Zhou, et al.
Cancers
|
January 10, 2026
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States
Jingyu Xu, Meng Shu, Hsingwen Chung, et al.
Acta Pharmaceutica Sinica. B
|
July 22, 2022
Targeting macrophagic SHP2 for ameliorating osteoarthritis <i>via</i> TLR signaling
Ziying Sun, Qianqian Liu, Zhongyang Lv, et al.
American Journal of Hematology
|
May 30, 2025
Identification of a CAR-Derived Clone by NGS-Based MRD After Fully Human BCMA CAR T-Cell Therapy in Multiple Myeloma
Wenqiang Yan, Jiao Chang, Chenxing Du, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 30, 2025
Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma
Jian Cui, Jingwei Wang, Xiaoyun Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 27, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)
Wenqiang Yan, Chenxing Du, Rui Lv, et al.
Leukemia
|
August 2, 2024
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma
Wenqiang Yan, Lihui Shi, Jingyu Xu, et al.
American Journal of Hematology
|
January 22, 2024
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma
Xuehan Mao, Wenqiang Yan, David Mery, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
Plos One
|
March 28, 2017
Common and rare exonic MUC5B variants associated with type 2 diabetes in Han Chinese
Guanjie Chen, Zhenjian Zhang, Sally N Adebamowo, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 22, 2023
Diagnostic efficiency of [68 Ga]Ga-DOTA-FAPI-04 in differentiating periprosthetic hip joint infection and aseptic failure
Yiqun Wang, Ruimin Wang, Xiaojun Zhang, et al.
Haematologica
|
April 24, 2025
The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significance-like behavior predict an exceptionally favorable prognosis in multiple myeloma
Wenqiang Yan, Chen Qiu, Jieqiong Zhou, et al.
Cancers
|
January 10, 2026
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States
Jingyu Xu, Meng Shu, Hsingwen Chung, et al.
Acta Pharmaceutica Sinica. B
|
July 22, 2022
Targeting macrophagic SHP2 for ameliorating osteoarthritis <i>via</i> TLR signaling
Ziying Sun, Qianqian Liu, Zhongyang Lv, et al.
American Journal of Hematology
|
May 30, 2025
Identification of a CAR-Derived Clone by NGS-Based MRD After Fully Human BCMA CAR T-Cell Therapy in Multiple Myeloma
Wenqiang Yan, Jiao Chang, Chenxing Du, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 30, 2025
Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma
Jian Cui, Jingwei Wang, Xiaoyun Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 27, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)
Wenqiang Yan, Chenxing Du, Rui Lv, et al.
Leukemia
|
August 2, 2024
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma
Wenqiang Yan, Lihui Shi, Jingyu Xu, et al.
American Journal of Hematology
|
January 22, 2024
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma
Xuehan Mao, Wenqiang Yan, David Mery, et al.
Page
of 12